ask="0.2290"
ask_size="400"
average_daily_volume="5775710"
bid="0.1800"
bid_size="6000"
book_value="0.1040"
change="-0.0061"
change_from_200_day_moving_average="-0.0660"
change_from_50_day_moving_average="-0.0098"
change_from_52_week_high="-0.4556"
change_From_52_week_low="0.0293"
change_in_percent="-3.2021%"
close="0.1844"
dividend_pay_date="N/A"
dividend_per_share="N/A"
dividend_yield="N/A"
earnings_per_share="-0.6780"
ebitda="-16.86M"
eps_estimate_current_year="-0.6200"
eps_estimate_next_quarter="0.0000"
eps_estimate_next_year="0.1700"
ex_dividend_date="N/A"
float_shares="125385000"
high="0.1940"
high_52_weeks="0.6400"
last_trade_date="2/14/2017"
last_trade_price="0.1844"
last_trade_size="384"
last_trade_time="4:00pm"
low="0.1820"
low_52_weeks="0.1551"
market_capitalization="24.21M"
moving_average_200_day="0.2504"
moving_average_50_day="0.1942"
name="Immune Pharmaceuticals Inc."
notes="N/A"
one_year_target_price="3.0000"
open="0.1890"
pe_ratio="N/A"
peg_ratio="0.0000"
percent_change_from_200_day_moving_average="-26.3690%"
percent_change_from_50_day_moving_average="-5.0669%"
percent_change_from_52_week_high="-71.1875%"
percent_change_from_52_week_low="+18.8910%"
previous_close="0.1905"
price_eps_estimate_current_year="N/A"
price_eps_Estimate_next_year="1.0847"
price_per_book="1.8317"
price_per_sales="N/A"
revenue="N/A"
shares_outstanding="131291000"
short_ratio="1.5300"
stock_exchange="NCM"
symbol="IMNP"
volume="3001634"
weeks_range_52="0.1551 - 0.6400"
